NHFG
MDGL icon

New Harbor Financial Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

New Harbor Financial Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-718
Closed -$201K – 75
2024
Q2 		$201K Sell
718
-193
-21% -$45.9K 0.06% 53
2024
Q1 		$243K Hold
911
– – 0.08% 37
2023
Q4 		$211K Buy
+911
New +$159K 0.08% 33
2023
Q3 		– Sell
-911
Closed -$210K – 50
2023
Q2 		$210K Hold
911
– – 0.06% 35
2023
Q1 		$221K Buy
+911
New +$248K 0.07% 27

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

New Harbor Financial Group's MDGL Position: Q3 2024 in Review

New Harbor Financial Group sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2024, closing a stake of 718 shares — an estimated $201K sold.

New Harbor Financial Group first reported a position in MDGL in Q1 2023 and held it in 5 quarters. The position peaked at $243K in Q1 2024. 257 funds tracked by Wall St. Rank hold MDGL as of Q3 2024.

  • New Harbor Financial Group reported no remaining Madrigal Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • New Harbor Financial Group sold 718 Madrigal Pharmaceuticals shares in Q3 2024, an estimated $201K.
  • New Harbor Financial Group first reported a position in Madrigal Pharmaceuticals in Q1 2023 and held it in 5 quarters.
  • New Harbor Financial Group's Madrigal Pharmaceuticals position peaked at $243K in Q1 2024.
  • 257 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2024.

Based on New Harbor Financial Group's 13F filing for Q3 2024, filed 16 Oct 2024.